Cell-based Therapies

27. März 2012, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen

Program

Tuesday, 27th March 2012


From 8:15	Registration and visit of the exhibition

9:00 – 9:40	Opening remarks and introduction Prof Dr Bernhard Fleckenstein Director, Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg Welcome Address Prof Dr Christoph Korbmacher Vice-President, Friedrich-Alexander-Universität Erlangen-Nürnberg Facilitating Cooperations Science - Industry Prof Dr Josef Nassauer Chief Executive, Bayern Innovativ GmbH, Nuremberg

	Strategies in Science and Industry Chair: Prof Dr Bernhard Fleckenstein

9:40 – 10:05	From stem cell to novel therapy – chances, challenges, reality Prof. Dr. Guido Nikkhah Director, Laboratory of Molecular Neurosurgery, University Hospitals Freiburg

10:30 -11:15	Coffee break in the exhibition

	Perspectives and Approaches Chair: Prof Dr Andreas Mackensen Director, Department of Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg

11:15- 11:40	Novel strategies for adoptive T-cell therapies Prof Dr Matthias Edinger Department of Haematology and Oncology, University Hospital Regensburg

11:40 – 12:05	Bringing cell therapies into clinical routine Stefan Miltenyi Managing Director, Miltenyi Biotec GmbH, Bergisch-Gladbach

12:05 – 12:30	The potential of imaging technologies and biomarkers visualizing cellular function Britta Fünfstück CEO, Siemens Molecular Imaging, Siemens AG Healthcare Sector, Hoffman Estates, IL, USA

12:30 – 14:00	Lunch break in the exhibition

	Technologies for Cell-based Therapies Chair: Dr Borris Haupt Bayern Innovativ GmbH, Nuremberg

14:00 – 14:25	Translational research allowing the manufacturing of cell therapeutics Prof Dr David Williams Director, Research School of Health and Life Sciences, Loughborough University, United Kingdom

14:25 – 14:50	Characterisation, production and quality control of mononuclear cells for clinical research and application Dr Erwin Strasser Department of Transfusion Medicine and Haemostaseology, University Hospital Erlangen

14:50 – 15:15	Influence of electromagnetic stimulation on stem cell differentiation Heribert Stephan CEO, Neue Magnetodyn GmbH, Munich PD Dr Susanne Mayer Department of Orthopaedic Surgery, Campus Großhadern, Ludwig-Maximilians-University, Munich

15:15 – 16:00	Coffee break in the exhibition

	Concepts and Clinical Applications of Cellular Therapies Chair: Prof Dr Jürgen Winkler Division of Molecular Neurology, University Hospital Erlangen; Speaker ForNeuroCell

16:00 – 16:25	Monocyte-derived dendritic cells in cancer immunotherapy Prof Dr Gerold Schuler Director, Department of Dermatology, University Hospital Erlangen

16:25 – 16:50	Bringing cell-based therapeutics to the market – obstacles and solutions Prof Dr Ralf Huss CSO, apceth GmbH & Co KG, Munich

16:50 – 17:15	Safety assessment and regulatory requirements for cell-based therapies Dr Gerhard Hager CEO, Aurigon Life Science GmbH, Tutzing

17:15 -17:30	Summary and Outlook Dr Matthias Konrad Bayern Innovativ GmbH, Nuremberg

From 17:30	Get-together in the exhibition